Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-Small Cell Lung Cancer

dc.authorwosid Barut, Zerrin/Izq-2308-2023
dc.contributor.author Akdeniz, Fatma Tuba
dc.contributor.author Barut, Zerrin
dc.contributor.author Avsar, Orcun
dc.contributor.author Arinc, Sibel
dc.contributor.author Isbir, Turgay
dc.date.accessioned 2025-11-15T14:59:10Z
dc.date.available 2025-11-15T14:59:10Z
dc.date.issued 2025
dc.department Okan University en_US
dc.department-temp [Akdeniz, Fatma Tuba] Istanbul Okan Univ, Fac Engn & Nat Sci, Dept Genet & Bioengn, Istanbul, Turkiye; [Barut, Zerrin] Antalya Bilim Univ, Fac Dent, Dept Basic Med Sci, Antalya, Turkiye; [Avsar, Orcun] Hitit Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Corum, Turkiye; [Arinc, Sibel] Sureyyapasa Training & Res Hosp Chest Dis & Thorac, Istanbul, Turkiye; [Sbir, Turgay] Yeditepe Univ, Inst Hlth Sci, Dept Mol Med, 26 Agustos Campus,Kayisdagi Cad 324A, TR-34755 Istanbul, Turkiye en_US
dc.description.abstract <bold>Background/Aim:</bold> Non-small cell lung cancer (NSCLC) is a type of lung cancer with a high mortality rate. Many molecular and biochemical mechanisms are involved in its development, among which the suppression of tumorigenicity-2 protein (ST2) signaling pathway. Soluble ST2 (sST2) competes with transmembrane ST2 (ST2 ligand) for IL-33 binding. Activation of IL-33/ST2 pathway leads to M2 macrophage polarization, which promotes tumor progression. Since Caspase-3 is implicated in the regulation of IL-33 activity, the present study aimed to analyze the serum levels of IL-33, sST2, and caspase-3 in non-small cell lung cancer patients, compare them with control samples, and simultaneously investigate their predictive capacity. <bold>Materials and Methods:</bold> In this study, sST2 protein, IL-33, and caspase-3 levels were investigated using the ELISA method in serum samples collected from 25 patients diagnosed with non-small cell lung cancer and 25 completely healthy volunteer individuals. In the study, receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic power of the biomarkers. <bold>Results:</bold> Serum IL-33 levels were found to be significantly elevated in patients compared to the control group (p<0.0001). Similarly, the patient group showed significantly higher caspase-3 serum levels than the control group (p<0.030). While sST2 serum levels were higher in the patient group, the difference did not reach statistical significance. The ROC analysis for IL-33 showed an area under the curve (AUC) value of 0.838 [95% confidence interval (CI)=0.725-0.952, p<0.05], indicating that IL-33 is good diagnostic capability for NSCLC. The AUC value for Caspase-3 was 0.678 (95% CI=0.525-0.832, p=0.023), while for sST2, the AUC value was 0.499 (95% CI=0.333-0.665, p>0.05). <bold>Conclusion:</bold> NSCLC patients are characterized by increased IL-33 and caspase-3 serum levels. These findings suggest that these markers could serve as valuable diagnostic and prognostic indicators, in addition to being potential therapeutic targets. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.21873/invivo.14127
dc.identifier.endpage 3286 en_US
dc.identifier.issn 0258-851X
dc.identifier.issn 1791-7549
dc.identifier.issue 6 en_US
dc.identifier.pmid 41167693
dc.identifier.scopus 2-s2.0-105020449269
dc.identifier.scopusquality Q3
dc.identifier.startpage 3278 en_US
dc.identifier.uri https://doi.org/10.21873/invivo.14127
dc.identifier.volume 39 en_US
dc.identifier.wos WOS:001608235100017
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.publisher International Institute of Anticancer Research en_US
dc.relation.ispartof In Vivo en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Non-Small Cell Lung Cancer en_US
dc.subject SST2 Protein en_US
dc.subject IL-33 en_US
dc.subject Caspase-3 en_US
dc.title Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-Small Cell Lung Cancer en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.coar.access open access
gdc.coar.type text::journal::journal article

Files